Related references
Note: Only part of the references are listed.A review of cancer immunotherapy toxicity
Lucy Boyce Kennedy et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Enhancing global access to cancer medicines
Javier Cortes et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Metascape provides a biologist-oriented resource for the analysis of systems-level datasets
Yingyao Zhou et al.
NATURE COMMUNICATIONS (2019)
Functional disparities within the TIMP family in cancer: hints from molecular divergence
Celina Eckfeld et al.
CANCER AND METASTASIS REVIEWS (2019)
Combination of TMB and CNA Stratifies Prognostic and Predictive Responses to Immunotherapy Across Metastatic Cancer
Li Liu et al.
CLINICAL CANCER RESEARCH (2019)
CancerSEA: a cancer single-cell state atlas
Huating Yuan et al.
NUCLEIC ACIDS RESEARCH (2019)
Matrisome-Associated Gene Expression Patterns Correlating with TIMP2 in Cancer
David Peeney et al.
SCIENTIFIC REPORTS (2019)
Personalized neoantigen vaccines: A new approach to cancer immunotherapy
Amanda R. Aldous et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2018)
Whole genome sequencing analysis for cancer genomics and precision medicine
Hidewaki Nakagawa et al.
CANCER SCIENCE (2018)
TIMP2 is a Poor Prognostic Factor and Predicts Metastatic Biological Behavior in Gastric Cancer
Wei Wang et al.
SCIENTIFIC REPORTS (2018)
Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers
Aaron M. Goodman et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer
Vinod P. Balachandran et al.
NATURE (2017)
GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses
Zefang Tang et al.
NUCLEIC ACIDS RESEARCH (2017)
Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden
Zachary R. Chalmers et al.
GENOME MEDICINE (2017)
TIMPs: versatile extracellular regulators in cancer
Hartland W. Jackson et al.
NATURE REVIEWS CANCER (2017)
Universal Patterns of Selection in Cancer and Somatic Tissues
Inigo Martincorena et al.
CELL (2017)
Role of Matrix Metalloproteinases in Photoaging and Photocarcinogenesis
Pavida Pittayapruek et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Association of Promoter Polymorphisms in MMP2 and TIMP2 with Prostate Cancer Susceptibility in North India
Priyanka Srivastava et al.
ARCHIVES OF MEDICAL RESEARCH (2012)
Human matrix metalloproteinases: An ubiquitarian class of enzymes involved in several pathological processes
Diego Sbardella et al.
MOLECULAR ASPECTS OF MEDICINE (2012)
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Ethan Cerami et al.
CANCER DISCOVERY (2012)
The tissue inhibitors of metalloproteinases (TIMPs): An ancient family with structural and functional diversity
Keith Brew et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2010)
The Anti-angiogenic Peptide, Loop 6, Binds Insulin-like Growth Factor-1 Receptor
Cecilia A. Fernandez et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function
David Warde-Farley et al.
NUCLEIC ACIDS RESEARCH (2010)
Oncomine 3.0: Genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles
Daniel R. Rhodes et al.
NEOPLASIA (2007)
Tissue inhibitor of metalloproteinase (TIMP)-1: The TIMPed balance of matrix metalloproteinases in the central nervous system
J Gardner et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2003)
Matrix metalloproteinases and tissue inhibitors of metalloproteinases - Structure, function, and biochemistry
R Visse et al.
CIRCULATION RESEARCH (2003)
Share Paper
